Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 18NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 9Plasma cell 8Other hematologic neoplasm 7Sarcoma 6Lymphoid 6Gastrointestinal 6Gynecologic 5Dermatologic 4CNS 3Myeloid 2Classical hematology 2Thoracic 1Other solid neoplasm 1Head & Neck 1

Conditions

Brain Neoplasms 3Melanoma 1Glioma 1

Interventions

Radiotherapy 63Temozolomide 59Magnetic Resonance Spectroscopy 46Carboplatin 40Cyclophosphamide 39Vincristine 35Specimen Handling 28Etoposide 26Cisplatin 26Radiation 22Chemotherapy, Adjuvant 22Filgrastim 20Bevacizumab 20Doxorubicin 18Peripheral Blood Stem Cell Transplantation 17Biopsy 17Vorinostat 16Surgical Procedures, Operative 14Melphalan 13Immunoglobulin G 13Disulfides 13Radiotherapy, Conformal 12Isotretinoin 12Erlotinib Hydrochloride 12X-Rays 11Nivolumab 11Irinotecan 11Carmustine 11aldesleukin 10Topotecan 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Thalidomide × CNS × Clear all
NCT00033254 2020-10-30

Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases

National Cancer Institute (NCI)

Phase 3 Completed
332 enrolled
CNS

Brain Neoplasms

NCT00072163 2013-01-17

Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma

National Cancer Institute (NCI)

Phase 2 Completed
50 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT00047879 2011-10-26

Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
7 enrolled 8 charts
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡